Does RISANKIZUMAB-RZAA Cause Condition aggravated? 665 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 665 reports of Condition aggravated have been filed in association with RISANKIZUMAB-RZAA. This represents 1.0% of all adverse event reports for RISANKIZUMAB-RZAA.
665
Reports of Condition aggravated with RISANKIZUMAB-RZAA
1.0%
of all RISANKIZUMAB-RZAA reports
2
Deaths
104
Hospitalizations
How Dangerous Is Condition aggravated From RISANKIZUMAB-RZAA?
Of the 665 reports, 2 (0.3%) resulted in death, 104 (15.6%) required hospitalization, and 1 (0.2%) were considered life-threatening.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 665 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Condition aggravated Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA